Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Immuneering Corporation (IMRX) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-14.96M |
|
-- |
|
-- |
|
$15.38M |
|
$-15.38M |
|
$0.42M |
|
$-14.96M |
|
$-14.96M |
|
$-14.96M |
|
$-14.96M |
|
$-14.96M |
|
$-14.96M |
|
$-15.38M |
|
$-15.21M |
|
39.67M |
|
39.67M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$229.10M |
|
$0.89M |
|
$11.95M |
|
$241.06M |
|
$9.55M |
|
-- |
|
$3.53M |
|
$13.08M |
|
$227.98M |
|
$220.96M |
|
$227.98M |
|
63.48M |
|
| Cash Flow Statement Financials | |
$-35.50M |
|
$-0.02M |
|
$226.94M |
|
$36.14M |
|
$227.56M |
|
$191.42M |
|
$4.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.00 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-35.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.56% |
|
-6.77% |
|
-6.21% |
|
-6.56% |
|
$3.59 |
|
$-0.90 |
|
$-0.90 |
|